LAS VEGAS — Onychomycosis, a stubborn fungal infection of the nail bed, is responsible for half of all nail diseases and presents a tricky challenge when it comes to both diagnosis and treatment. “The ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. No prescription was prescribed in 82% of the dermatology ...

Please provide your email address to receive an email when new articles are posted on . Treatment efficacy was achieved by 76.67% of the continuous regimen group vs. 26.67% of the pulsed group (P = ...

Overcoming onychomycosis is the perfect choice to reduce the causes of ugly nail fungus. This program provides a comprehensive guide to natural remedies to treat onychomycosis for the reader. Nail ...

Onychomycosis is the most common disease of nails, with a prevalence of up to 14% in Western adult populations. Whereas tinea unguium refers strictly to dermatophyte fungal infection of the nail plate ...

WASHINGTON, Jan. 31, 2024 /PRNewswire/ -- Vanda Pharmaceuticals Inc. (Vanda) (Nasdaq: VNDA) today announced that the U.S. Food and Drug Administration (FDA) has approved the Investigational New Drug ...

Toenail fungus, or onychomycosis, is a nail infection that can make your toenails thicker, change color, or break apart. It affects about one in 10 people and is common in adults over 60. While fungi ...

Daewoong Pharmaceutical announced on the 24th that it has launched an 8ml version of Juplie topical solution, a treatment for onychomycosis (onychomycosis of fingernails and toenails). Developed by ...

LOS ALTOS, Calif.--(BUSINESS WIRE)--TOPICA Pharmaceuticals, Inc., a privately held biotechnology company, today announced that it’s ready to advance its 10% solution of luliconazole into Phase 3 ...